Polylactide-polyglycolide antibiotic implants

Kevin Garvin1, Connie Feschuk

  • 1University of Nebraska Medical Center, Omaha, 68198, USA. kgarvin@unmc.edu

Insights

New biodegradable polymers offer a promising solution for delivering antibiotics directly to treat bone infections, minimizing side effects and improving effectiveness in orthopaedic surgery.

Area of Science:

  • Orthopaedic Surgery
  • Biomaterials Science
  • Infectious Disease Treatment

Background:

  • Orthopaedic infections pose a significant challenge, with current treatments lacking optimal effectiveness and side effect profiles.
  • While plaster of paris and polymethylmethacrylate (PMMA) have been used for localized antibiotic delivery, they present limitations such as inconsistent elution and the need for implant removal.
  • There is a critical need for advanced antibiotic delivery systems that are effective, well-tolerated, and absorbable.

Purpose of the Study:

  • To evaluate the potential of biodegradable polymers for localized antibiotic delivery in treating orthopaedic infections.
  • To explore antibiotic-impregnated polylactic acid, polyglycolic acid, or polyparadioxanone as absorbable systems for sustained antibiotic release.
  • To investigate the feasibility of antibiotic-polymer composites for managing bone infections.

Main Methods:

  • Review of existing literature on antibiotic delivery systems in orthopaedics.
  • Analysis of in vitro studies demonstrating antibiotic elution from bioabsorbable microspheres and beads.
  • Examination of in vivo animal studies (rabbits, dogs) using antibiotic-impregnated polymers to treat induced osteomyelitis.

Main Results:

  • In vitro studies show promising antibiotic elution profiles from biodegradable microspheres and beads.
  • In vivo animal testing demonstrated successful treatment of osteomyelitis using antibiotic-impregnated polymers.
  • Consistent and reproducible results in animal models suggest clinical potential.

Conclusions:

  • Biodegradable polymers represent a viable and effective platform for localized antibiotic delivery in orthopaedic infections.
  • Further research and human trials are warranted to assess the efficacy of antibiotic microspheres and polymer-coated components.
  • This approach holds the potential to improve treatment outcomes for chronic osteomyelitis and reduce associated side effects.

Related Concept Videos

Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...